SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Dynavax DVAX -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (135)8/9/2017 9:12:34 PM
From: scaram(o)uche  Respond to of 184
 
"Dynavax anticipates using the net proceeds from the proposed offering to fund activities associated with preparing for the anticipated U.S. commercial launch of HEPLISAV-B"

Ah, now it makes sense. It's the Berkeley Fourth St. Fever. Primary symptom is commitment to the silliest of all possible routes.

One city block, five or six of the worst CEOs ever known to the sector. Bug must grow in Aquatic Park.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News